Advancing Stem Cell Therapies: From Research to Reality
DRA symposium
The field of stem cell therapy is transforming modern medicine, offering new possibilities for treating and potentially curing a wide range of diseases. What are the driving forces behind these advancements? What are the current capabilities and limitations of stem cell therapies, and how are they influencing the future of healthcare? How are research institutions and industry leaders applying these innovations in practice? Join us for a focused half-day seminar with leading experts to explore these questions and examine the scientific and clinical progress shaping the future of stem cell therapy.
This seminar combines national and international highly recognized experts from the industry, academia and spin-outs providing an overview of the possibilities and challenges associated with using stem cell therapies in the pharmaceutical value chain, thus offering a great learning opportunity for participants to expand their knowledge within this area.
Programme
| 12:30 |
Welcome and introduction Stine Rønholt, LEO Foundation Center for Cutaneous Drug Delivery / Danish Pharmaceutical Society & Lasse Saaby, Department of Pharmacy |
| 12:35 |
Advancements in Preclinical and Clinical Stem Cell Therapies for the Central Nervous System Agnete Kirkeby, Assoc. Prof., University of Copenhagen |
| 13:05 |
Translating Knowledge on Stem Cells and Tissue Regeneration into Clinical Practice |
| 13:35 |
Mesenchymal Stromal Cells to Treat Patients with Non-Ischaemic Heart Failure Morten Juhl Nørgaard, Cardiology Stem Cell Centre, Rigshospitalet |
| 14:05 |
Coffee and refreshments |
| 14:25 |
Advancing Cancer Immunotherapy: 25 Years of Progress in T-Cell Based Therapies Inger Marie Svane, Professor, Director, National Center for Cancer Immune Therapy, Herlev Hospital |
| 14:55 |
Elucidating the Functional Consequences of Contact Between Macrophages and T Cells Kolade Adebowale, Assistant Prof. University of San Diego |
| 15:25 |
Making stem cells available for therapy Anette Ekblond, Director of R&D, Cell2Cure |
| 15:55 |
Coffee and refreshments |
| 16:10 |
Lessons Learned from Development of Stem Cell-based Therapies Jacob Petersen, SVP, Novo Nordisk |
| 16:40 |
Navigating the Way from Laboratory to Human Testing in Stem Cell-based Therapies Thomas Hassing Bronøe Carlsen, CEO Accelerator Denmark |
| 17:10 |
Charting the Course: Regulatory Frameworks in Cell Therapy Development |
| 17:40 |
Wrap up Hanne Mørck Nielsen, Danish Pharmaceutical Society |
The symposium is free of charge and open for attendance by all interested parties. As the event includes coffee and refreshments, we kindly ask you to PRE-REGISTER via Danmarks Farmaceutiske Selskab no later than 6 May.
The symposium is organized on behalf of the graduate programme in pharmaceutical sciences, Drug Research Academy, by Associate Professor Stine Rønholt, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen in collaboration with the Section for Biopharmaceuticals, Danish Pharmaceutical Society.